Optiray 300 Interactions
There are 148 drugs known to interact with Optiray 300 (ioversol), along with 7 disease interactions. Of the total drug interactions, 86 are major, and 62 are moderate.
- View all 148 medications that may interact with Optiray 300
- View Optiray 300 disease interactions (7)
Most frequently checked interactions
View interaction reports for Optiray 300 (ioversol) and the medicines listed below.
- Albutein (albumin human)
- Amikin (amikacin)
- Aminosyn (parenteral nutrition solution)
- azithromycin
- calcium gluconate
- caspofungin
- cefepime
- cefoperazone
- cefotaxime
- ceftazidime
- ceftriaxone
- colistin sulfate / hydrocortisone / neomycin / thonzonium bromide otic
- diazepam
- dopamine
- ertapenem
- famotidine
- fentanyl
- fluconazole
- furosemide
- ibuprofen
- immune globulin intravenous
- Intralipid (fat emulsion)
- ketamine
- levofloxacin
- linezolid
- mannitol
- meropenem
- metronidazole
- nystatin
- omeprazole
Optiray 300 disease interactions
There are 7 disease interactions with Optiray 300 (ioversol) which include:
- hyperthyroidism
- pheochromocytoma
- sickle cell disease
- myasthenia gravis
- asthma/allergies
- acute renal failure
- cardiovascular disease
More about Optiray 300 (ioversol)
- Optiray 300 consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.